Dr. Sandra Fernando Sieminski, MD

Dr. Sieminski practices at University Ophthalmology Services Inc. in Buffalo, New York.

Dr. Sieminski's NPI, 1578739793, was assigned on May 7, 2008. Dr. Sieminski graduated from University of Pittsburgh School of Medicine in 2005. Dr. Sieminski holds New York license 252535.

Dr. Sieminski's primary practice is University Ophthalmology Services Inc., at 3540 Sheridan Dr, Buffalo, NY 14226 in Erie County. The practice phone is (716) 834-0013.

Dr. Sieminski's primary practice is University Ophthalmology Services Inc. in Buffalo, New York. Dr. Sieminski is also affiliated with Mercy Hospital of Buffalo. Dmand AI also links Dr. Sieminski to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sieminski practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sieminski's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sieminski is licensed in New York.

CMS data shows 1,243 Medicare services from Dr. Sieminski across 16 procedure codes in 2024, for 384 Medicare patients. Medicare paid $117,220 for them.

CMS counts 384 Medicare patients who saw Dr. Sieminski in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sieminski's median patient age at 74, with 55% women.

In 2024, Dr. Sieminski wrote 6,247 Medicare Part D claims for 995 patients. 66% of them were for generic drugs. CMS names the drug for 6,143 of them, across 31 drugs with 11 or more claims each, at $727,254 in total drug cost. In 2023, CMS named 6,586 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sieminski for performance year 2024, reported as part of a group. Dr. Sieminski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 135 procedures of cataract surgery by Dr. Sieminski, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Sieminski, published from 2012 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Intraocular Pressure, Tonometry, Ocular and Ciliary Body. Dr. Sieminski has published most often in Am J Ophthalmol Case Rep. Dr. Sieminski's most frequent co-authors are Patrice M. Hicks, MD, Adam R. Siedlecki and Preethi S. Ganapathy, MD.

Dmand AI links Dr. Sieminski to 1 clinical trial. Conditions studied include Glaucoma and Ocular Hypertension.

CMS Open Payments shows 205 general payments to Dr. Sieminski from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 29% of the total. Iridex Corporation paid the most, $23,905. It also lists 2 research payments totaling $3,412 in 2025.

Dr. Sieminski graduated from University of Pittsburgh School of Medicine in 2005.